000 | 02376na a2200253 4500 | ||
---|---|---|---|
003 | PC10414 | ||
005 | 20180417112807.0 | ||
008 | 130622s2011 xxx||||| |||| 00| 0 eng d | ||
040 | _cH12O | ||
041 | _aspa | ||
100 |
_9876 _aAguado García, José María _eEnfermedades Infecciosas |
||
100 |
_aLizasoaín Hernández, Manuel _9870 _eMedicina Interna |
||
100 |
_aLumbreras Bermejo, Carlos _9873 _eMedicina Interna |
||
245 | 0 | 0 |
_aRecomendaciones sobre el tratamiento de la enfermedad fungica invasiva por Aspergillus spp. y otros hongos filamentosos de la Sociedad Espanola de Enfermedades Infecciosas y Microbiologia Clinica (SEIMC). Actualizacion 2011. _h[artículo] |
260 |
_bEnfermedades Infecciosas y Microbiología Clínica, _c2011. |
||
300 | _a29(6):435-454. | ||
500 | _aFormato Vancouver: Fortún J, Carratalá J, Gavaldá J, Lizasoain M, Salavert M, de la Cámara R, Borges M, Cervera C, Garnacho J, Lassaleta Á, Lumbreras C, Sanz MÁ, Ramos JT, Torre-Cisneros J, Aguado JM, Cuenca-Estrella M; Grupo de Estudio de Micología Médica de la SEIMC (GEMICOMED). [Guidelines for the treatment of invasive fungal disease by Aspergillus spp. and other fungi issued by the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC). 2011 Update]. Enferm Infecc Microbiol Clin. 2011;29(6):435-54. | ||
501 | _aPMID: 21474210 | ||
504 | _aContiene 229 referencias. | ||
520 | _2The guidelines on the treatment of invasive fungal disease by Aspergillus spp. and other fungi issued by the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) are presented. These recommendations are focused on four clinical categories: oncology-haematology patients, solid organ transplant recipients, patients admitted to intensive care units, and children. An extensive review is made of therapeutical advances and scientific evidence in these settings. These guidelines have been prepared according the SEIMC consensus rules by a working group composed of specialists in infectious diseases, clinical microbiology, critical care medicine, paediatrics and oncology-haematology. Specific recommendations on the prevention of fungal infections in these patients are included. | ||
710 |
_96 _aServicio de Medicina Interna |
||
856 |
_uhttp://pc-h12o-es.m-hdoct.a17.csinet.es/pdf/pc10414.pdf _ySolicitar documento |
||
942 |
_2ddc _cART _n0 |
||
999 |
_c10414 _d10414 |